Winston Tan
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 44
- Prostate Cancer Diagnosis and Treatment 12
- Renal cell carcinoma treatment 9
- Oncology 44
- HER2/EGFR in Cancer Research 13
- Cancer Treatment and Pharmacology 12
- Co-authors
- David W. Hillman (18 shared papers)Gerardo Colón‐Otero (2 shared papers)Alexandra Drakaki (1 shared paper)Peter H. O’Donnell (1 shared paper)Sunil Sharma (1 shared paper)Zev A. Wainberg (1 shared paper)Jason J. Luke (1 shared paper)John F. Kurland (1 shared paper)
- Journals
- Journal of Clinical Oncology (31 papers)Cancers (5 papers)Prostate Cancer and Prostatic Diseases (5 papers)Clinical Cancer Research (4 papers)Cancer Research (4 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Winston Tan
108 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 1.4k
- Cancer Research 690
- Pulmonary and Respiratory Medicine 1.1k
- Geriatrics and Gerontology 122
- Applied Microbiology and Biotechnology 50
Countries citing papers authored by Winston Tan
This map shows the geographic impact of Winston Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winston Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winston Tan more than expected).
Fields of papers citing papers by Winston Tan
This network shows the impact of papers produced by Winston Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winston Tan. The network helps show where Winston Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Winston Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer Hit paper breakdown → | 2016 | 661 |
| 2 | Management of Cancer Cachexia: ASCO Guideline Hit paper breakdown → | 2020 | 373 |
| 3 | 2016 | 255 | |
| 4 | 2013 | 224 | |
| 5 | 2003 | 205 | |
| 6 | 2008 | 154 | |
| 7 | 2008 | 91 | |
| 8 | 2020 | 89 | |
| 9 | 2018 | 85 | |
| 10 | 2019 | 83 | |
| 11 | 2005 | 76 | |
| 12 | 2016 | 67 | |
| 13 | 2007 | 53 | |
| 14 | 2005 | 51 | |
| 15 | 2016 | 47 | |
| 16 | 2013 | 47 | |
| 17 | 2015 | 47 | |
| 18 | 2019 | 44 | |
| 19 | 2020 | 44 | |
| 20 | 2006 | 40 |
About Winston Tan
Winston Tan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 117 papers that have together received 3.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (44 papers), Cancer Genomics and Diagnostics (17 papers), HER2/EGFR in Cancer Research (13 papers), Cancer Treatment and Pharmacology (12 papers), Radiopharmaceutical Chemistry and Applications (12 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Cancer, Lipids, and Metabolism (9 papers) and Renal cell carcinoma treatment (9 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (690 citations), Pulmonary and Respiratory Medicine (1.1k citations), Geriatrics and Gerontology (122 citations) and Applied Microbiology and Biotechnology (50 citations). Winston Tan has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include David W. Hillman, Gerardo Colón‐Otero, Alexandra Drakaki, Peter H. O’Donnell, Sunil Sharma, Zev A. Wainberg, Jason J. Luke, John F. Kurland, Rachel E. Sanborn and Omid Hamid. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Prostate Cancer and Prostatic Diseases, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.